Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 1, 2006, Pages 114-123

  Sova, Pavel ^a,b   Feng, Qinghua ^a   Geiss, Gary ^a   Wood, Troy ^a   Strauss, Robert ^a   Rudolf, Vania ^a   Lieber, Andre ^a   Kiviat, Nancy ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BIOLOGICAL MARKER; GENE PRODUCT; METALLOTHIONEIN I; METALLOTHIONEIN IG; NMES1 PROTEIN; OSTEONECTIN; PLACENTA PROTEIN 5; RAS PROTEIN; RRAD PROTEIN; SFRP1 PROTEIN; TRICHOSTATIN A; TUMOR MARKER; UNCLASSIFIED DRUG; AZACITIDINE; DNA; DRUG DERIVATIVE; ENZYME INHIBITOR; HISTONE DEACETYLASE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DIAGNOSTIC VALUE; DISEASE MARKER; DNA DETERMINATION; DNA HYBRIDIZATION; DNA MICROARRAY; FEMALE; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; ONCOGENE; PRIORITY JOURNAL; SPARC GENE; TUMOR CELL LINE; UTERINE CERVIX CARCINOMA; DNA METHYLATION; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; MICROARRAY ANALYSIS; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GENE; UPREGULATION; UTERINE CERVIX; UTERINE CERVIX TUMOR;

AZACITIDINE; CELL LINE, TUMOR; CERVIX UTERI; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HISTONE DEACETYLASES; HUMANS; MICROARRAY ANALYSIS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 33645461015     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0323     Document Type: Article

References (36)

1. Kulasingam SL, Hughes JP, Kiviat, et al. A. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002;288:1749-57.
2. Wright TC, Jr., Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9.
3. Fife KH, Wheeler CM, Koutsky, et al. Dose-ranging studies of the safety and immunogenicity of human papillomavirus type 11 and type 16 virus-like particle candidate vaccines in young healthy women. Vaccine 2004; 22:2943-52.
4. Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer 2003;3:253-66.
5. Widschwendter A, Muller HM, Fiegl, et al. DNA methylation in serum and tumors of cervical cancer patients. Clin Cancer Res 2004; 10:565-71.
6. Reesink-Peters N, Wisman GB, Jeronimo, et al. G. Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study. Mol Cancer Res 2004;2:289-95.
7. Narayan G, Arias-Pulido H, Koul, et al. Frequent promoter methylation of CDH1, DAPK, RARB, HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer 2003;2:24.
8. Feng Q, Balasubramanian A, Hawes SE, et al. Detection of hypermethylated genes in women with and without cervical neoplasia. J Natl Cancer Inst 2005;97:273-82.
9. Suzuki H, Gabrielson E, Chen W, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002;31:141-9.
10. Sato N, Fukushima N, Maitra, et al. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 2003;63:3735-42.
11. Xi LF, Toure P, Critchlow, et al. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age. Int J Cancer 2003;103:803-9.
12. Saeed AI, Sharov V, White J, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003;34:374-8.
13. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-8.
14. Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001;29:365-71.
15. Stone B, Schummer M, Paley PJ, et al. Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q. Int J Cancer 2003;104:73-84.
16. Worm J, Aggerholm A, Guldberg P. In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin Chem 2001;47:1183-9.
17. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6.
18. Eads CA, Danenberg KD, Kawakami K, et al. W. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000;28:E32.
19. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002;18:1427-31.
20. Grunau C, Clark SJ, Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 2001;29:E65-5.
21. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999;21:103-7.
22. Smiraglia DJ, Rush LJ, Fruhwald MC, et al. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 2001;10:1413-9.
23. Goberdhan DC, Wilson C. PTEN: tumour suppressor, multifunctional growth regulator and more. Hum Mol Genet 2003;12 Spec No 2:R239-48.
24. Hube F, Reverdiau P, Iochmann S, Rollin J, Cherpi-Antar C, Gruel Y. Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells. Biol Chem 2003;384:1029-34.
25. Andreu T, Beckers T, Thoenes E, Hilgard P, von Melchner H. Gene trapping identifies inhibitors of oncogenic transformation. The tissue inhibitor of metalloproteinases-3 (TIMP3) and collagen type I alpha2 (COL1A2) are epidermal growth factor-regulated growth repressors. J Biol Chem 1998;273:13848-54.
26. Yamashita K, Upadhyay S, Osada M, et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in s. Cancer Cell 2002; 2:485-95.
27. Sato N, Fukushima N, Maehara N, et al. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions. Oncogene 2003;22:5021-30.
28. Framson PE, Sage EH. SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 2004;92:679-90.
29. Konduri SD, Srivenugopal KS, Yanamandra N, et al. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. Oncogene 2003;22:4509-16.
30. Rollin J, Iochmann S, Blechet C, et al. Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer. Br J Cancer 2005;92:775-83.
31. Huang Y, de la Chapelle A, Pellegata NS. Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma. Int J Cancer 2003;104:735-44.
32. Reynet C, Kahn CR. Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans. Science 1993;262:1441-4.
33. Suzuki M, Toyooka S, Shivapurkar N, et al. Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene 2005;24:1302-8.
34. Zhou J, Wang H, Lu A, et al. A novel gene, NMES1, downregulated in human esophageal squamous cell carcinoma. Int J Cancer 2002; 101:311-6.
35. Zendman AJ, Ruiter DJ, Van Muijen GN. Cancer/testis-associated genes: identification, expression profile, and putative function. J Cell Physiol 2003;194:272-88.
36. Pivot-Pajot C, Caron C, Govin J, Vion A, Rousseaux S, Khochbin S. Acetylation-dependent chromatin reorganization by BRDT, a testis-specific bromodomain-containing protein. Mol Cell Biol 2003; 23:5354-65.